This company looks a good buying opportunity in the short term. Raising at 3c just about fully underwritten on a two for one basis to existing shares. Over time this should track up to the 3c mark, which is a tidy 65% gain from the current price.
- Forums
- ASX - By Stock
- Ann: Company Update
Featured News
Add MKO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online